Effects of Sialidase Inhibitor on Proliferation and Apoptosis of Endometrial Cancer Cells

XIONG Ying, ZHANG Jian-guo, SU Dong-mei. et al

Abstract

To explore the effects of sialidase inhibitor on the proliferation and apoptosis of endometrial cancer Ishikawa cells. Methods Ishikawa cells were cultured and divided into 2 groups: control group and sialidase inhibitor N-Acetyl-2,3-dehydro-2-deoxyneuraminic acid （DANA） treated group. After the sialidase activity was compared between the two groups, the expression level of matrix metalloproteinases (MMPs), proliferating cell nuclear antigen (PCNA), apoptosis rate and proliferation ability were detected by immunofluorescence staining, flow cytometry or MTT assay. Results With the treatment of DANA, the activity of sialidase in the cell culture supernatant was suppressed while MMPs expression levels and apoptosis rate of Ishikawa cells were decreased. The expression level of PCNA and cell proliferation showed no statistical differences in two groups. Conclusion Sialidase could affect the invasive ability and apoptosis rate of Ishikawa cells, but it seems no effect on cell proliferation.

 

Keywords: Sialidase, Tumor, Proliferation, Apoptosis 

 

Full Text:

PDF


References


MIYAGI T. YAMAGUCHI К. Mammalian sialidases; physiological and pathological roles in cellular functions. Glycobiology .2012.22(7): 880-896.

MIYAGI T, TAKAHASHI K, SHIOZAKI K, et al. Plasma membrane-associated sialidase confers cancer initiation, promotion and progression. Adv Exp Med Biol,2015(842) : 139-145.

LI Y, CHEN X. Sialic acid metabolism and sialyltransferases; natural functions and applications. Appl Microbiol Biotechnol,2012,94(4) ;887-905.

MIYAGI T, TAKAHASHI К. HATA K, et al , Sialidase significance for cancer progression. Glycoconj J.2012, 29(8 9): 567-577.

LI X, ZHANG L, SHAO Y, et al. Effects of a human plasma membrane-associated sialidase siRNA on prostate cancer invasion. Biochem Biophys Res Commun, 2011, 416 (3/4) :270-276.

SHIGA K, TAKAHASHI K, SATO I, et al. Upregulation of sialidase NEU3 in head and neck squamous cell carcinoma associated with lymph node metastasis. Cancer Sci,2015,106 (11): 1544-1553.

MIYATAM, КАМНЕ M, TAJIMA О, et al. Membrane sialidase NEU3 is highly expressed in human melanoma cells promoting cell growth with minimal changes in the composition of gangliosides. Cancer Sci,2011,102(12):2139- 2149.

ТАК AH ASH 1 K, HOSONO M, SATO L et al. Sialidase NEU3 contributes neoplastic potential on colon cancer cells as a key modulator of gangliosides by regulating Wnt signaling. Int J Cancer,2015,137(7): 1560-1573.

ZHANG Y, ALBOHY A. ZOU Y, et al. Identification of selective inhibitors for human neuraminidase isoenzymes using C4, C7-modified 2-deoxy-2, 3-didehydro-N- acetylneuraminic acid (DANA) analogues. J Med Chem, 2013,56(7):2948-2958.

HAKOMORI SI, HANDA K. GM3 and cancer. Glycoconj J,2015,32( 1/2); 1-8.

YOSHINAGA А» KAJIYA N, OISHI K. et at. NFAJ3 inhibitory effect of naringin suppresses cancer cell growth by attenuation of EGFR signaling through GM3 ganglioside accumulation. Eur J Pharmacol,2016(782):21-29.

LI Y. HUANG X. WANG C, et al. Ganglioside GM3 exerts opposite effects on motility via epidermal growth factor receptor and hepatocyte growth factor receptor-mediated migration signaling. Mol Med Rep,2015,11 (4):2959-2966.

SCARINGI R. PICCOLI M, PAPINI N, el at. NFAJ3 sialidase is activated under hypoxia and protects skeletal muscle cells from apoptosis through the activation of the epidermal growth factor receptor signaling pathway and the hypoxia-inducible factor ( HIF)-la. J Biol Chem. 2013, 288 (5):3153-3162.

Li J» MCCLANE BA. The Sialidases of Clostridium perfringens type I) strain CN3718 differ in their properties and sensitivities to inhibitors. Appl Environ Microbiol,2014, 80(5):1701-1709.

DEBERARDINIS RJ, LUM JJ. HATZIVASSILIOU G, et al. The biology of cancer; metabolic reprogramming fuels cell growth and proliferation. Cell Metab, 2008.7( 1): 11-20.

GILLIES RJ, ROBEY I. GATENBY RA. Causes and consequences of increased glucose metabolism of cancers. J Nucl Med.2008,49 Suppl 2;24S-42S.

HSU PP, SABATINI DM. Cancer cell metabolism: Warburg and beyond. Cell,2008,134(5);703-707.

GOETZE K, WALENTA S, KSIAZKIEWICZ M, et al. Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release. Int J Oncol,2011, 39(2) ;453-463.

HIRSCHHAEUSER F. SATTLER UG, MUELLER- KLIESER W. Lactate; a metabolic key player in cancer. Cancer Res,2011,71 (22); 6921-6925.

MONTERO JC, RODRIGUEZ-BARRUECO R, OCANA A, et al. Neuregulins and cancer. Clin Cancer Res, 2008, 14 (11);3237-3241.

GARRATT AN. “To erb-B or not to erb-B... ” Neuregulin- 1/ErbB signaling in heart development and function. J Mol Cell Cardiol,2006,41(2) ,215-218.

HERNANDEZ L, SMIRNOVA T, KEDRIN D, et al. The EGF/CSF-1 paracrine invasion loop can be triggered by hprpgnlin hptal япН Г.ХС1.1?. СЯПРРГ RPS,2009,69(7) :Я221- 3227.

KUSH IMA Y, I IDA K, NAGAOKA Y, et al. Inhibitory effect of ( — )-epigallocatechin and ( — )-epigallocatechin gallate against heregulin betal-induced migration/invasion of the MCF-7 breast carcinoma cell line. Biol Pharm Bull,2009,

ZHOU M, ZHAO Y. DING Y. et al. Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re- sensitizes taxol-resistant cancer cells to taxol. Mol Cancer. 2010(9) :33. doi; 10. 1186/1476-4598-9-33.

ZHAO YH, ZHOU M. LIU H. et al. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth. Oncogene,2009,28(42):3689-3701.

YUSTE L. MONTERO JC, ESPARIS-OGANDO A, et al. Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin. Cancer Res,2005,65( 15) ;6801-6810.

CHENG L, ZHA Z, LANG B, et al. Heregulin-betal promotes metastasis of breast cancer cell line SKBR3 through upregulation of Snail and induction of epithelial-mesenchymal transition. Cancer Lett ,2009,280(1);50-60.

RUAN SQ, WANG SW, WANG ZH. et al. Regulation of HRG-betal-induced proliferation, migration and invasion of MCF-7 cells by upregulation of GPR30 expression. Mol Med Rep,2012,6(1):131-138.

RUAN SQ, WANG ZH, WANG SW, et al. Heregulin- betal-induced GPR30 upregulation promotes the migration and invasion potential of SkBr3 breast cancer cells via ErbB2 ErbB3-MAPK/ERK pathway. Biochem Biophys Res Commun,2012,420(2) ;385-390.

ELSTROM RL, BAUER DE, BUZZAI M. et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res, 2004,64(11):3892-3899.


Refbacks

  • There are currently no refbacks.